|7th November 2019
Many stakeholders are confused by precision medicines, including patients and healthcare professionals. So, how can industry help them to navigate this complexity? At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video below to get a run down on three core components to consider when commercialising these innovative products.
|1st November 2019
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?